Prevalence of germline MSH3 polymorphisms in ulcerative colitis and early-onset colorectal cancer patients that potentiates inflammation-to-cancer transformation
Human Molecular Genetics · 2026
DOI: 10.1093/hmg/ddaf181 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Molecular Genetics, 2026. Verfasst von Stephanie S Tseng-Rogenski und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, University of Michigan, 1500 E. Medical Center Drive, Ann Arbor, MI 48109, United States. Hauptthemen laut MEDLINE: Colitis, Ulcerative, MutS Homolog 3 Protein, Colorectal Neoplasms, Cell Transformation, Neoplastic. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, United States Public Health Service.
Themen: Onkologische Pflege
Abstract (Originalsprache)
The DNA mismatch repair protein MSH3 reversibly shifts from nucleus to the cytosol upon IL-6 signaling, abrogating the repair function of the MSH3-MSH2 heterodimer in the nucleus and increases aggressiveness and metastasis potential of colorectal cancers. A polymorphism proximate to MSH3’s nuclear localization signal (NLS), Δ27bpMSH3, alters NLS function such that IL-6 triggers Δ27bpMSH3 accumulation in the cytosol. Public databases indicate Δ27bpMSH3 is rare in the germline yet we previously identified its presence in half of colon cancer cell lines tested and 19% of ulcerative colitis (UC) tissue samples. Here in examining ~ 200 each of UC, early-onset (eo)CRC, and late-onset (lo)CRC patients, biallelic MSH3 NLS germline polymorphisms were exclusively present in 15% of controls but in 18% of UC and 17% of eoCRC patients and were higher among CRC stage 3/4 patients compared to stage 2 patients; these marginal increases could potentiate inflammation-to-cancer transformation and/or metastatic disease. Using cell models we demonstrate IL-6-induced binding of wild type and Δ27bpMSH3 to the NFκB activating complex NEMO/IKKγ which stabilizes MSH3 after disengaging from its nuclear partner MSH2, linking inflammation with DNA repair protein stability. Additional NLS modifications using MSH3-FLAG mimics cytosolic Δ27bpMSH3 retention to cause loss-of-function after inflammation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, University of Michigan, 1500 E. Medical Center Drive, Ann Arbor, MI 48109, United States.
- Division of Gastroenterology and Hepatology, Department of Medicine, University of California San Diego, 9500 Gilman Drive, San Diego, CA 92093, United States.
- Moores Cancer Center, University of California San Diego, 9500 Gilman Drive, San Diego, CA 92093, United States.
- Herbert Wertheim School of Public Health and Longevity Science, University of California San Diego, 9500 Gilman Drive, San Diego, CA 92093, United States.
ORCID-Profile: John M Carethers
Förderung
- NCI NIH HHS
- United States Public Health Service
Zitieren
APA
Tseng-Rogenski, S. S., Venugopal, A., Koi, M., & Carethers, J. M. (2026). Prevalence of germline MSH3 polymorphisms in ulcerative colitis and early-onset colorectal cancer patients that potentiates inflammation-to-cancer transformation. Human Molecular Genetics. https://doi.org/10.1093/hmg/ddaf181
Vancouver
Tseng-Rogenski SS, Venugopal A, Koi M, Carethers JM. Prevalence of germline MSH3 polymorphisms in ulcerative colitis and early-onset colorectal cancer patients that potentiates inflammation-to-cancer transformation. Human Molecular Genetics. 2026. doi:10.1093/hmg/ddaf181
BibTeX
@article{TsengRogenski2026,
author = {Tseng-Rogenski, Stephanie S and Venugopal, Anand and Koi, Minoru and Carethers, John M},
title = {Prevalence of germline MSH3 polymorphisms in ulcerative colitis and early-onset colorectal cancer patients that potentiates inflammation-to-cancer transformation},
journal = {Human Molecular Genetics},
year = {2026},
doi = {10.1093/hmg/ddaf181}
}
EUVIMED